Discontinued — last reported Q4 '21
Products & Services · Net revenues
Other Womens Health — Net revenues
AbbVie Other Womens Health — Net revenues decreased by 1.8% to $56.00M in Q4 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ4 2021
Rolls up toTotal Revenue
How to read this metric
An increase indicates successful market penetration and demand for the company's specialized women's health portfolio, while a decrease may signal competitive pressure or product lifecycle maturity.
Detailed definition
This metric represents the total net sales generated from the company's portfolio of products specifically categorized u...
Peer comparison
Peers in the pharmaceutical industry often report similar specialized therapeutic segments, though specific product groupings vary significantly based on individual company portfolios.
Metric ID:
abbv_segment_other_women_s_health_net_revenuesHistorical Data
3 periods
| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $55.00M | $57.00M | $56.00M |
| QoQ Change | — | +3.6% | -1.8% |
Range$55.00M – $57.00M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's other womens health — net revenues?
- AbbVie (ABBV) reported other womens health — net revenues of $56.00M in Q4 2021.
- What does other womens health — net revenues mean?
- The total revenue generated from the sale of specialized women's health pharmaceutical products.